Close Menu

NEW YORK – Laboratory Corporation of America today said that its second quarter revenues were down 4 percent year over year but beat the consensus Wall Street estimate.

For the three months ended June 30, the Burlington, North Carolina-based firm reported $2.77 billion in revenues, down from $2.88 billion in Q2 2019, but above analysts' average estimate of $2.5 billion.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.


As worldwide COVID-19 cases continue to rise, there is a significant need to increase testing and population surveillance capacity.

Sponsored by

This webinar will present a case study from in vitro diagnostics developer SpeeDx on its experience building a complete sample-to-result workflow — encompassing instrumentation and data analysis software — for its qPCR-based ResistancePlus MG Mycoplasma genitalium assay.